Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 20 
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, Reid CM, Lockery JE, Kirpach B, Storey E, Shah RC, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Johnston CI, Ryan J, Radziszewska B, Jelinek M, Malik M, Eaton CB, Brauer D, Cloud G, Wood EM, Mahady SE, Satterfield S, Grimm R, Murray AM, for the ASPREE Investigator Group. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med 2018;379:18 de octubre. [Ref.ID 102843]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, Storey E, Shah RC, Lockery JE, Tonkin AM, Newman AB, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Ryan J, Radziszewska B, Grimm R, Murray AM, for the ASPREE Investigator Group. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med 2018;379:18 de octubre. [Ref.ID 102842]
3.
Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf 2006;29:277-302. [Ref.ID 77478]
4.
Vale M, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL, Ho BP, Newman R W, McNeil JJ, for The COACH Study. Coaching patients on achieving cardiovascular health (COACH). A multicenter randomized trial in patients with coronary heart disease. Arch Intern Med 2003;163:2775-83. [Ref.ID 68432]
5.Tiene citas relacionadas Cita con resumen
Wing LMH, Reid C M, Ryan P, Beilin LJ, Brown MA, Jennings GLR, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ, for the Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-92. [Ref.ID 65045]
7.
Ioannides-Demos LL, Ibrahim J, McNeil JJ. Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes. Pharmacoeconomics 2002;20:577-91. [Ref.ID 62875]
8.
Taylor H, Tikellis G, Robman L D, McCarty CA, McNeil JJ. Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ 2002;325:11-4. [Ref.ID 62709]
9.
Buchbinder R, Forbes A, Kobben F, Boyd I, Snow RM, McNeil JJ. Clinical features of tiaprofenic acid (Surgam) associated cystitis and a study of risk factors for its development. J Clin Epidemiol 2000;53:1013-9. [Ref.ID 53291]
10.
Gourlay SG, Forbes A, Marriner T, McNeil JJ. Predictors and timing of adverse experiences during transdermal nicotine therapy. Drug Saf 1999;20:545-55. [Ref.ID 45132]
11.
Thrift AG, Donnan GA, McNeil JJ. Heavy drinking, but not moderate or intermediate drinking, increases the risk of intracerebral hemorrhage. Epidemiology 1999;10:307-12. [Ref.ID 43967]
12. Cita con resumen
13.
Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR. Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA 1996;276:961-6. [Ref.ID 29226]
14.
Thrift AG, Donnan GA, McNeil JJ. Epidemiology of intracerebral hemorrhage. Epidemiol Rev 1995;17:361-81. [Ref.ID 26762]
15.
Gourlay SG, Forbes A, Marrimer T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994;309:842-6. [Ref.ID 22711]
16. Cita con resumen
Silagy CA, McNeil JJ, Donnan GA, Tonkin AM, Worsam B, Campion K. Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther 1993;54:84-9. [Ref.ID 19925]
17.
Sim MR, McNeil JJ. Monitoring chemical exposure using breast milk: a methodological review. Am J Epidemiol 1992;136:1-11. [Ref.ID 18552]
18. Cita con resumen
Fairley CK, McNeil JJ, Desmond P, Smallwood R, Young HJ, Forbes A, Purcell P, Boyd I. Risk factors for development of flucoxacillin associated jaundice. BMJ 1993;306:233-5. [Ref.ID 18450]
19.
McNeil JJ. New drugs for hypercholesterolaemia. Australian Prescriber 1990;13:71-2. [Ref.ID 15866]
20.
McLean AJ, Harcourt DM, McNeil JJ. Relapse rate as a major determinant of drug selection in peptic ulcer therapy. Drugs 1988;35:329-33. [Ref.ID 11659]
Seleccionar todas
 
 1 a 20 de 20